Mychem: Maravai LifeSciences Acquires Nucleotide Maker MyChem for at Least $240M
MyChem provides modified nucleotides and other chemicals used in mRNA synthesis for the diagnostics, pharmaceutical, genomics, and research markets.
Read full article »
MyChem is a California-based biotechnology company that develops and commercializes ultra-pure nucleotides that include natural, modified and dye-labeled nucleotides.
Read more